{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-018221","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.888804+00:00","generated_at":"2026-05-26T01:04:50.545253+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Astrana Health enters $1.295B credit facility; $745M delayed draw for Prospect acquisition","bullets":["Five-year $300M revolver, $250M term A loan, and $745M delayed draw term loan.","Delayed draw term loan to finance acquisition of assets from Prospect Medical Holdings (agreement Nov 8, 2024).","Covenants: max total net leverage 5.00x (falling to 4.50x after Mar 2027); min interest coverage 2.50x.","Borrower and subsidiary Astrana Health Management grant security interest in all assets to lenders.","Annual meeting set for June 11, 2025; virtual; record date April 22, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-018221","json":"https://secwatch.observer/filing/0001104659-25-018221.json","markdown":"https://secwatch.observer/filing/0001104659-25-018221.md","text":"https://secwatch.observer/filing/0001104659-25-018221.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925018221/0001104659-25-018221-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925018221/tm257416d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T01:04:50.545253+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a38e249d4f44fcc1c494e1882ba742a99a04d334","claim":"Astrana Health, Inc. amended term loan of $745,000,000 with Truist Bank (as administrative agent) at term SOFR plus 1.25% to 2.50% or base rate plus 0.25% to 1.50% maturing five years from the closing date.","evidence_excerpt":"(c) a five-year delayed draw term loan credit facility to the Company of $745,000,000","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925018221/0001104659-25-018221-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$745,000,000"},{"label":"Counterparty","value":"Truist Bank (as administrative agent)"},{"label":"Rate","value":"term SOFR plus 1.25% to 2.50% or base rate plus 0.25% to 1.50%"},{"label":"Maturity","value":"five years from the closing date"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"ff4d2290685833722d88ce58a564144a5a9d6db1","claim":"Astrana Health, Inc. amended revolving credit of $300,000,000 with Truist Bank (as administrative agent) at term SOFR plus 1.25% to 2.50% or base rate plus 0.25% to 1.50% maturing five years from the closing date.","evidence_excerpt":"provides for (a) a five-year revolving credit facility to the Company of $300,000,000","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465925018221/0001104659-25-018221-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"$300,000,000"},{"label":"Counterparty","value":"Truist Bank (as administrative agent)"},{"label":"Rate","value":"term SOFR plus 1.25% to 2.50% or base rate plus 0.25% to 1.50%"},{"label":"Maturity","value":"five years from the closing date"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}